Immune-Related Adverse Events in Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors: Insights From a FAERS Disproportionality Analysis. Gokhale P, Zapata LV. Cancer Med 2026;15:e71777.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gokhale P, Zapata LV. Immune-Related Adverse Events in Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors: Insights From a FAERS Disproportionality Analysis. Cancer Med 2026;15:e71777.
PMID: 41925086